MedBound Times

mail@medbound.com
Connect :
FILE - AbbVie's signature drug Humira is shown in this photo illustration, in Houston, Texas, July 18, 2014.
Patient financial assistance initiatives set up by drugmakers, which some benefit managers have complained encourage patients to stay on expensive brand-name drugs when less expensive options might be available.
Behind Florida’s decision to block clinical services for transgender adolescents is a talking point — repeated by the state’s governor and top medical authorities — that most cases of gender incongruence fade over time.
Read More
Medbound
www.medboundtimes.com